BCL2 and type 2 diabetes mellitus: The expression of GAS5 is reduced in T2D patients with endometrial cancer [188] and its over-expression induces BCL2, also reducing the expression of the pro-apoptotic proteins BCL2 associated agonist of cell death (BAD) and BAX [189].